SLP
Price:
$20.49
Market Cap:
$412.76M
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Ab...[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
1997-06-18
Stock Exchange
NASDAQ
Ticker
SLP
According to Simulations Plus, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.36. This represents a change of -102.46% compared to the average of 258.57 of the last 4 quarters.
The mean historical PE Ratio of Simulations Plus, Inc. over the last ten years is 64.73. The current -6.36 PE Ratio has changed -1082.53% with respect to the historical average. Over the past ten years (40 quarters), SLP's PE Ratio was at its highest in in the November 2024 quarter at 773.74. The PE Ratio was at its lowest in in the May 2025 quarter at -2.38.
Average
64.73
Median
73.19
Minimum
-4.40
Maximum
113.77
Discovering the peaks and valleys of Simulations Plus, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 81.99%
Maximum Annual PE Ratio = 113.77
Minimum Annual Increase = -106.05%
Minimum Annual PE Ratio = -4.40
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.40 | -106.05% |
| 2024 | 72.79 | -18.82% |
| 2023 | 89.66 | -7.71% |
| 2022 | 97.15 | 7.02% |
| 2021 | 90.78 | -20.21% |
| 2020 | 113.77 | 54.59% |
| 2019 | 73.59 | 81.99% |
| 2018 | 40.44 | -6.37% |
| 2017 | 43.19 | 42.35% |
| 2016 | 30.34 | 2.43% |
The current PE Ratio of Simulations Plus, Inc. (SLP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
52.68
5-year avg
69.20
10-year avg
64.73
Simulations Plus, Inc.’s PE Ratio is less than SOPHiA GENETICS S.A. (-4.60), less than Definitive Healthcare Corp. (-1.41), less than OptimizeRx Corporation (7.98K), less than Alto Neuroscience, Inc. (-5.58), greater than Cellectis S.A. (-8.31), less than Kindly MD, Inc. (-1.24), less than Korro Bio, Inc. (-0.70), less than Agilon Health, Inc. (-0.98), less than National Research Corporation (22.53), less than AC Immune S.A. (-4.61),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.60 | $336.95M | |
| -1.41 | $264.46M | |
| 7.98K | $270.94M | |
| -5.58 | $415.67M | |
| -8.31 | $484.47M | |
| -1.24 | $207.24M | |
| -0.70 | $63.86M | |
| -0.98 | $301.74M | |
| 22.53 | $371.73M | |
| -4.61 | $289.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Simulations Plus, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Simulations Plus, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Simulations Plus, Inc.'s PE Ratio?
How is the PE Ratio calculated for Simulations Plus, Inc. (SLP)?
What is the highest PE Ratio for Simulations Plus, Inc. (SLP)?
What is the 3-year average PE Ratio for Simulations Plus, Inc. (SLP)?
What is the 5-year average PE Ratio for Simulations Plus, Inc. (SLP)?
How does the current PE Ratio for Simulations Plus, Inc. (SLP) compare to its historical average?